Arthritis drug ‘tocilizumab’ improves survival in critically ill COVID-19 patients: Study
Boston: Anti-inflammatory drug ‘tocilizumab’ has been shown to reduce mortality by 30 per cent among critically ill COVID-19 patients. This ...
Read moreDetails